(R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 17060667.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Is there scientific evidence to support the replacement of the beta-agonist racemic albuterol with levalbuterol--that is, (R)-albuterol? The argument presented further refines the question as "Do we wish to continue to treat asthma with a mixture of albuterol, of which half is an agent with no known benefit--that is, (S)-albuterol--and which may exacerbate the disease?"
Medical subject headings
- Adrenergic beta-Agonists
- Albuterol
- Asthma